Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Aspartylglucosaminidase
Introduction
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase is an enzyme that in humans is encoded by the AGA gene.[1]
Aspartylglucosaminidase is an amidohydrolase enzyme involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. The lysosomal storage disease aspartylglycosaminuria is caused by a deficiency in the AGA enzyme.[1]
External links
External links
- Human AGA genome location and AGA gene details page in the UCSC Genome Browser.
Further reading
Further reading
- Ikonen E, Peltonen L (1993). “Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease”. Hum. Mutat. 1 (5): 361–5. doi:10.1002/humu.1380010503. PMID 1301945.
- Mononen I, Fisher KJ, Kaartinen V, Aronson NN (1993). “Aspartylglycosaminuria: protein chemistry and molecular biology of the most common lysosomal storage disorder of glycoprotein degradation”. FASEB J. 7 (13): 1247–56. PMID 8405810.
- Enomaa N, Heiskanen T, Halila R, et al. (1992). “Human aspartylglucosaminidase. A biochemical and immunocytochemical characterization of the enzyme in normal and aspartylglucosaminuria fibroblasts”. Biochem. J. 286 ( Pt 2) (Pt 2): 613–8. PMC 1132942. PMID 1530592.
- Ikonen E, Baumann M, Grön K, et al. (1991). “Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease”. EMBO J. 10 (1): 51–8. PMC 452610. PMID 1703489.
- Morris C, Heisterkamp N, Groffen J, et al. (1992). “Chromosomal localization of the human glycoasparaginase gene to 4q32-q33”. Hum. Genet. 88 (3): 295–7. doi:10.1007/BF00197262. PMID 1733831.
- Ikonen E, Enomaa N, Ulmanen I, Peltonen L (1992). “In vitro mutagenesis helps to unravel the biological consequences of aspartylglucosaminuria mutation”. Genomics. 11 (1): 206–11. doi:10.1016/0888-7543(91)90120-4. PMID 1765378.
- Park H, Fisher KJ, Aronson NN (1991). “Genomic structure of human lysosomal glycosylasparaginase”. FEBS Lett. 288 (1–2): 168–72. doi:10.1016/0014-5793(91)81027-6. PMID 1840528.
- Mononen T, Mononen I, Matilainen R, Airaksinen E (1991). “High prevalence of aspartylglycosaminuria among school-age children in eastern Finland”. Hum. Genet. 87 (3): 266–8. doi:10.1007/BF00200902. PMID 1864600.
- Fisher KJ, Aronson NN (1991). “Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. Amino acid substitution Cys163—-Ser abolishes the activity of lysosomal glycosylasparaginase and its conversion into subunits”. J. Biol. Chem. 266 (18): 12105–13. PMID 1904874.
- Mononen I, Heisterkamp N, Kaartinen V, et al. (1991). “Aspartylglycosaminuria in the Finnish population: identification of two point mutations in the heavy chain of glycoasparaginase”. Proc. Natl. Acad. Sci. U.S.A. 88 (7): 2941–5. doi:10.1073/pnas.88.7.2941. PMC 51356. PMID 2011603.
- Halila R, Baumann M, Ikonen E, et al. (1991). “Human leucocyte aspartylglucosaminidase. Evidence for two different subunits in a more complex native structure”. Biochem. J. 276 ( Pt 1) (Pt 1): 251–6. PMC 1151172. PMID 2039475.
- Fisher KJ, Tollersrud OK, Aronson NN (1991). “Cloning and sequence analysis of a cDNA for human glycosylasparaginase. A single gene encodes the subunits of this lysosomal amidase”. FEBS Lett. 276 (1–2): 232. doi:10.1016/0014-5793(90)80551-S. PMID 2265705.
- Fisher KJ, Tollersrud OK, Aronson NN (1990). “Cloning and sequence analysis of a cDNA for human glycosylasparaginase. A single gene encodes the subunits of this lysosomal amidase”. FEBS Lett. 269 (2): 440–4. doi:10.1016/0014-5793(90)81211-6. PMID 2401370.
- Tollersrud OK, Aronson NN (1989). “Purification and characterization of rat liver glycosylasparaginase”. Biochem. J. 260 (1): 101–8. PMC 1138631. PMID 2775174.
- Hreidarsson S, Thomas GH, Valle DL, et al. (1983). “Aspartylglucosaminuria in the United States”. Clin. Genet. 23 (6): 427–35. doi:10.1111/j.1399-0004.1983.tb01977.x. PMID 6883788.
- Enomaa NE, Lukinmaa PL, Ikonen EM, et al. (1993). “Expression of aspartylglucosaminidase in human tissues from normal individuals and aspartylglucosaminuria patients”. J. Histochem. Cytochem. 41 (7): 981–9. doi:10.1177/41.7.7685790. PMID 7685790.
- McCormack AL, Mononen I, Kaartinen V, Yates JR (1995). “Localization of the disulfide bond involved in post-translational processing of glycosylasparaginase and disrupted by a mutation in the Finnish-type aspartylglycosaminuria”. J. Biol. Chem. 270 (7): 3212–5. doi:10.1074/jbc.270.7.3212. PMID 7852406.
- Tollersrud OK, Heiskanen T, Peltonen L (1994). “Human leucocyte glycosylasparaginase is an alpha/beta-heterodimer of 19 kDa alpha-subunit and 17 and 18 kDa beta-subunit”. Biochem. J. 300 ( Pt 2) (Pt 2): 541–4. PMC 1138195. PMID 8002961.
External links
External links
- Aspartylglucosylaminase at the US National Library of Medicine Medical Subject Headings (MeSH)